(Q83340919)

English

Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone

scientific article published on 01 July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

splenic marginal zone lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Apostolia Maria Tsimberidou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Guillermo Garcia-Manero

7

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Daniel Catovsky

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ellen Schlette

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Susan O'Brien

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

William G Wierda

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Hagop Kantarjian

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sijin Wen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Kim-Anh Do

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Susan Lerner

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Michael J Keating

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

107

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

125-135

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Splenic marginal zone lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hématologie Cellulaire (GFHC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic features of splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 abnormalities in splenic lymphoma with villous lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21931

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21931

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16700034%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83340919&oldid=1809606192"